NYXH
Nyxoah SA
Price Chart
Latest Quote
$0.91
+0.05 (+6.35%)
Current Price
| Previous Close | $0.86 |
| Open | $0.93 |
| Day High | $0.93 |
| Day Low | $0.89 |
| Volume | 295,915 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 101.84M |
| Total Debt | $66.76M |
| Cash Equivalents | $108.82M |
| Revenue | $24.11M |
| Net Income | $-106.84M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $92.76M |
| EPS (TTM) | $-2.33 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $47.91M |
| Sales | $24.11M |
| Income | $-106.84M |
| Book/sh | $0.93 |
| Cash/sh | $0.96 |
| Employees | 153 |
Financial Ratios
| Quick Ratio | 2.28 |
| Current Ratio | 2.38 |
| Debt/Eq | 72.18 |
Returns & Margins
| ROA | -36.87% |
| ROE | -122.68% |
| Gross Margin | 60.19% |
| Operating Margin | -268.25% |
Ownership
| Insider Ownership | 33.19% |
| Institutional Ownership | 30.28% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.10 |
| P/S | 4.28 |
| P/B | 0.98 |
Analyst Data
| Recommendation | buy |
| Target Price | $2.78 |
Technical Indicators
| SMA20 | $1.17 |
| SMA50 | $1.39 |
| SMA200 | $2.56 |
| RSI | 13.98 |
| ATR | 0.0721 |
| Shares Float | 50.88M |
| Short Float | 0.36% |
| Short Ratio | 0.57 |
| Volatility | 1.00 |
| Rel Volume | 1.39 |
Performance History
| Week | -3.11% |
| Month | -42.72% |
| Quarter | -34.47% |
| 6 Months | -69.74% |
| YTD | -79.76% |
| Year | -83.76% |
| 3 Years | -85.12% |
| 5 Years | -96.04% |
| 10 Years | -96.21% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $0.91 | 295,915 |
| 2026-10-26 | $0.86 | 232,400 |
| 2026-10-23 | $0.83 | 181,000 |
| 2026-10-22 | $0.82 | 643,700 |
| 2026-10-21 | $0.89 | 413,400 |
| 2026-10-20 | $0.94 | 469,000 |
| 2026-10-19 | $0.95 | 484,200 |
| 2026-10-16 | $1.11 | 210,200 |
| 2026-10-15 | $1.19 | 131,300 |
| 2026-10-14 | $1.25 | 91,600 |
| 2026-10-13 | $1.28 | 58,600 |
| 2026-10-12 | $1.31 | 144,500 |
| 2026-10-09 | $1.36 | 36,100 |
| 2026-10-08 | $1.35 | 87,900 |
| 2026-10-07 | $1.42 | 81,500 |
| 2026-10-06 | $1.43 | 132,400 |
| 2026-10-05 | $1.41 | 191,300 |
| 2026-10-02 | $1.36 | 68,500 |
| 2026-10-01 | $1.33 | 120,800 |
| 2026-09-30 | $1.38 | 189,800 |
| 2026-09-29 | $1.37 | 337,300 |
| 2026-09-28 | $1.59 | 642,600 |
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
đ° Latest News
No news articles available at the moment. Check back later for updates on NYXH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $596,848 | $131,888 | $377,780 | $147,535 |
| Cost Of Revenue | $4,128,758 | $1,734,660 | $1,850,900 | $1,285,347 |
| Total Revenue | $11,199,285 | $5,053,091 | $4,859,730 | $3,446,966 |
| Operating Revenue | $11,199,285 | $5,053,091 | $4,859,730 | $3,446,966 |
| Expenses | ||||
| Interest Expense | $2,065,497 | $990,276 | $242,539 | $264,893 |
| Total Expenses | $103,902,986 | $70,783,504 | $55,269,924 | $39,770,874 |
| Rent Expense Supplemental | $551,023 | $714,206 | $354,309 | $491,785 |
| Other Income Expense | $-2,144,853 | $1,987,258 | $-1,033,866 | $3,223,427 |
| Net Non Operating Interest Income Expense | $-4,714,429 | $669,498 | $1,531,240 | $-492,903 |
| Total Other Finance Cost | $4,698,782 | $1,136,694 | $1,099,810 | $643,791 |
| Interest Expense Non Operating | $2,065,497 | $990,276 | $242,539 | $264,893 |
| Operating Expense | $99,774,228 | $69,048,844 | $53,419,024 | $38,485,527 |
| Other Operating Expenses | $-1,472,002 | $-1,126,635 | $-608,025 | $-316,307 |
| General And Administrative Expense | $51,902,314 | $30,375,545 | $23,074,774 | $20,052,532 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Net Interest Income | $-4,714,429 | $669,498 | $1,531,240 | $-492,903 |
| Interest Income | $2,049,849 | $2,796,468 | $2,873,589 | $415,782 |
| Normalized Income | $-99,078,743 | $-67,698,112 | $-47,297,342 | $-37,317,537 |
| Net Income From Continuing And Discontinued Operation | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Total Operating Income As Reported | $-93,310,608 | $-65,730,414 | $-50,410,194 | $-36,323,908 |
| Net Income Common Stockholders | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Net Income | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Net Income Including Noncontrolling Interests | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Net Income Continuous Operations | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Pretax Income | $-99,559,631 | $-63,073,657 | $-49,912,821 | $-33,593,384 |
| Special Income Charges | $-610,260 | $0 | $0 | - |
| Interest Income Non Operating | $2,049,849 | $2,796,468 | $2,873,589 | $415,782 |
| Operating Income | $-92,703,701 | $-65,730,414 | $-50,410,194 | $-36,323,908 |
| Depreciation Amortization Depletion Income Statement | $1,479,826 | $1,435,118 | $1,164,636 | $1,021,571 |
| Depreciation And Amortization In Income Statement | $1,479,826 | $1,435,118 | $1,164,636 | $1,021,571 |
| Gross Profit | $7,070,527 | $3,318,431 | $3,008,830 | $2,161,618 |
| Per Share | ||||
| Diluted EPS | $-2.64 | $-2.02 | $-1.73 | $-1.35 |
| Basic EPS | $-2.64 | $-2.02 | $-1.73 | $-1.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $-536,213 | $496,815 | $-33,454 | $805,857 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-90,337,545 | $-61,032,749 | $-45,998,660 | $-34,392,534 |
| Total Unusual Items | $-2,144,853 | $1,987,258 | $-1,033,866 | $3,223,427 |
| Total Unusual Items Excluding Goodwill | $-2,144,853 | $1,987,258 | $-1,033,866 | $3,223,427 |
| Reconciled Depreciation | $5,011,736 | $3,037,890 | $2,637,756 | $2,159,383 |
| EBITDA (Bullshit earnings) | $-92,482,398 | $-59,045,491 | $-47,032,526 | $-31,169,107 |
| EBIT | $-97,494,134 | $-62,083,381 | $-49,670,281 | $-33,328,491 |
| Diluted Average Shares | $42,591,956 | $36,599,043 | $31,259,799 | $28,866,805 |
| Basic Average Shares | $42,591,956 | $36,599,043 | $31,259,799 | $28,866,805 |
| Diluted NI Availto Com Stockholders | $-100,687,383 | $-66,207,668 | $-48,297,754 | $-34,899,967 |
| Tax Provision | $1,127,752 | $3,134,011 | $-1,615,067 | $1,306,583 |
| Gain On Sale Of Ppe | $-181,066 | $0 | $0 | - |
| Other Special Charges | $-133,005 | - | - | - |
| Write Off | $562,200 | $0 | $0 | - |
| Gain On Sale Of Security | $-1,534,593 | $1,987,258 | $-1,033,866 | $3,223,427 |
| Research And Development | $47,864,089 | $38,364,816 | $29,787,639 | $17,727,730 |
| Selling General And Administration | $51,902,314 | $30,375,545 | $23,074,774 | $20,052,532 |
| Other Gand A | $21,428,412 | $16,341,791 | $11,621,773 | $8,875,601 |
| Insurance And Claims | $481,726 | $571,141 | $1,100,928 | $1,681,010 |
| Rent And Landing Fees | $551,023 | $714,206 | $354,309 | $491,785 |
| Salaries And Wages | $29,441,154 | $12,748,407 | $9,997,765 | $9,004,136 |
Fetched: 2026-10-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,094,222 | $70,272,718 | $57,465,073 | $89,808,876 |
| Total Assets | $132,414,219 | $177,049,293 | $138,769,422 | $163,262,549 |
| Total Non Current Assets | $63,996,872 | $67,422,601 | $62,373,981 | $51,202,639 |
| Non Current Deferred Assets | $97,239 | $84,945 | $62,591 | $52,532 |
| Non Current Deferred Taxes Assets | $97,239 | $84,945 | $62,591 | $52,532 |
| Non Current Accounts Receivable | $1,818,487 | $1,682,128 | $1,303,230 | $193,361 |
| Financial Assets | $101,710 | $125,182 | - | - |
| Goodwill And Other Intangible Assets | $56,005,366 | $56,310,496 | $52,093,440 | $44,676,429 |
| Other Intangible Assets | $56,005,366 | $56,310,496 | $52,093,440 | $44,676,429 |
| Current Assets | $68,417,348 | $109,626,692 | $76,395,441 | $112,059,910 |
| Hedging Assets Current | $4,471 | $0 | $383,369 | $1,118 |
| Current Deferred Assets | $741,031 | $1,026,042 | - | - |
| Prepaid Assets | $343,132 | $820,387 | - | - |
| Inventory | $5,208,450 | $5,271,041 | $3,705,153 | $985,805 |
| Receivables | $8,469,878 | $6,884,989 | $6,289,259 | $3,617,973 |
| Other Receivables | $1,004,806 | $1,195,932 | $1,353,526 | $858,388 |
| Taxes Receivable | $1,592,713 | $1,909,020 | $1,853,135 | $1,124,399 |
| Accounts Receivable | $5,872,360 | $3,780,038 | $3,082,598 | $1,635,185 |
| Cash Cash Equivalents And Short Term Investments | $53,650,386 | $95,624,233 | $64,544,541 | $106,019,897 |
| Cash And Cash Equivalents | $33,531,911 | $38,209,456 | $24,153,348 | $19,993,294 |
| Cash Equivalents | $24,735,666 | $31,541,299 | $10,235,833 | $40,237 |
| Cash Financial | $8,796,245 | $6,668,157 | $13,917,514 | $19,953,057 |
| Other Current Assets | - | $1,850,900 | $1,473,120 | $1,435,118 |
| Debt | ||||
| Net Debt | $10,124,064 | - | - | - |
| Total Debt | $45,238,628 | $25,319,102 | $14,199,173 | $13,281,547 |
| Long Term Debt And Capital Lease Obligation | $18,672,181 | $23,792,333 | $12,841,176 | $12,043,143 |
| Long Term Debt | $17,960,210 | $20,928,803 | $9,358,444 | $9,152,789 |
| Current Debt And Capital Lease Obligation | $26,566,447 | $1,526,769 | $1,357,997 | $1,238,404 |
| Current Debt | $25,695,764 | $277,188 | $406,840 | $434,783 |
| Other Current Borrowings | $25,695,764 | $277,188 | $406,840 | $434,783 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $77,503,075 | $50,466,079 | $29,210,909 | $28,777,244 |
| Total Non Current Liabilities Net Minority Interest | $22,783,056 | $26,403,264 | $13,068,068 | $12,109,087 |
| Derivative Product Liabilities | $1,789,427 | - | - | - |
| Non Current Deferred Liabilities | $761,149 | $548,787 | $10,059 | $0 |
| Non Current Deferred Taxes Liabilities | $0 | $21,236 | $10,059 | $0 |
| Current Liabilities | $54,720,019 | $24,062,815 | $16,142,841 | $16,668,157 |
| Other Current Liabilities | $1,686,599 | $1,627,361 | $324,131 | $10,059 |
| Current Deferred Liabilities | $999,218 | $130,770 | $0 | - |
| Payables And Accrued Expenses | $24,850,788 | $19,768,638 | $13,576,618 | $14,735,666 |
| Payables | $10,453,784 | $9,015,313 | $6,806,751 | $6,323,908 |
| Total Tax Payable | $4,677,546 | $4,825,081 | $2,221,974 | $4,084,051 |
| Accounts Payable | $5,776,238 | $4,190,231 | $4,584,777 | $2,093,439 |
| Other Non Current Liabilities | - | $944,451 | - | $1,118 |
| Other Payable | - | - | $223,539 | $146,418 |
| Equity | ||||
| Common Stock Equity | $54,911,144 | $126,583,214 | $109,558,513 | $134,485,305 |
| Total Equity Gross Minority Interest | $54,911,144 | $126,583,214 | $109,558,513 | $134,485,305 |
| Stockholders Equity | $54,911,144 | $126,583,214 | $109,558,513 | $134,485,305 |
| Other Equity Interest | $13,853,806 | $10,394,546 | $8,562,647 | $6,309,378 |
| Gains Losses Not Affecting Retained Earnings | $1,256,287 | $1,021,571 | $153,124 | $196,714 |
| Other Equity Adjustments | $1,256,287 | $1,021,571 | $153,124 | $196,714 |
| Retained Earnings | $-342,046,502 | $-243,360,907 | $-179,757,464 | $-132,124,737 |
| Other | ||||
| Ordinary Shares Number | $48,090,377 | $41,832,196 | $32,048,715 | $28,888,208 |
| Share Issued | $48,090,377 | $41,832,196 | $32,048,715 | $28,888,208 |
| Tangible Book Value | $-1,094,222 | $70,272,718 | $57,465,073 | $89,808,876 |
| Invested Capital | $98,567,119 | $147,789,206 | $119,323,798 | $144,072,876 |
| Working Capital | $13,697,329 | $85,563,878 | $60,252,600 | $95,391,753 |
| Capital Lease Obligations | $1,582,653 | $4,113,111 | $4,433,889 | $3,693,976 |
| Total Capitalization | $72,871,355 | $147,512,018 | $118,916,957 | $143,638,093 |
| Additional Paid In Capital | $374,576,959 | $351,341,238 | $275,094,450 | $255,141,392 |
| Capital Stock | $7,270,594 | $7,186,767 | $5,505,756 | $4,962,557 |
| Common Stock | $7,270,594 | $7,186,767 | $5,505,756 | $4,962,557 |
| Non Current Deferred Revenue | $761,149 | $527,551 | $0 | - |
| Long Term Capital Lease Obligation | $711,971 | $2,863,530 | $3,482,732 | $2,890,354 |
| Long Term Provisions | $1,560,300 | $1,117,693 | $206,773 | $65,944 |
| Current Deferred Revenue | $999,218 | $130,770 | $0 | - |
| Current Capital Lease Obligation | $870,683 | $1,249,581 | $951,157 | $803,621 |
| Pensionand Other Post Retirement Benefit Plans Current | $616,967 | $1,009,277 | $884,095 | $684,028 |
| Current Accrued Expenses | $14,397,005 | $10,753,325 | $6,769,867 | $8,411,758 |
| Net PPE | $5,974,070 | $9,219,850 | $8,914,720 | $6,280,318 |
| Accumulated Depreciation | $-5,522,522 | $-6,358,556 | $-4,541,187 | $-3,091,539 |
| Gross PPE | $11,496,591 | $15,578,406 | $13,455,907 | $9,371,857 |
| Leases | $4,600,425 | $2,052,085 | $1,468,649 | $786,856 |
| Construction In Progress | $33,531 | $2,524,869 | $2,296,859 | $802,504 |
| Other Properties | $1,993,964 | $2,125,852 | $1,677,657 | $1,397,116 |
| Machinery Furniture Equipment | $2,968,593 | $3,222,309 | $2,866,883 | $2,334,861 |
| Buildings And Improvements | $1,900,078 | $5,653,292 | $5,145,859 | $4,050,520 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,669,833 | $1,218,285 | $509,668 | $317,425 |
| Work In Process | $2,068,850 | $2,845,647 | $1,710,070 | $111,769 |
| Raw Materials | $1,469,766 | $1,207,109 | $1,485,414 | $556,611 |
| Other Short Term Investments | $20,118,476 | $57,414,777 | $40,391,193 | $86,026,603 |
| Employee Benefits | - | $0 | $10,059 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | - | $0 | $10,059 | $0 |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-10-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-81,309,938 | $-61,806,193 | $-62,300,213 | $-50,413,547 |
| Operating Activities | ||||
| Operating Cash Flow | $-77,097,352 | $-55,019,561 | $-50,048,062 | $-32,140,383 |
| Cash Flow From Continuing Operating Activities | $-77,097,352 | $-55,019,561 | $-50,048,062 | $-32,140,383 |
| Operating Gains Losses | $1,715,659 | $-1,987,258 | $1,033,866 | $-3,223,427 |
| Investing Activities | ||||
| Capital Expenditure | $-4,212,585 | $-6,786,633 | $-12,252,152 | $-18,273,164 |
| Investing Cash Flow | $31,666,481 | $-18,246,340 | $35,778,474 | $-100,532,024 |
| Cash Flow From Continuing Investing Activities | $31,666,481 | $-18,246,340 | $35,778,474 | $-100,532,024 |
| Capital Expenditure Reported | $-3,312,842 | $-5,484,520 | $-9,457,919 | $-17,282,888 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $23,319,549 | $77,927,798 | $20,495,138 | $285,012 |
| Financing Cash Flow | $42,591,931 | $86,553,036 | $18,842,070 | $-1,098,692 |
| Cash Flow From Continuing Financing Activities | $42,591,931 | $86,553,036 | $18,842,070 | $-1,098,692 |
| Net Other Financing Charges | $-3,633,620 | $-292,836 | $-57,002 | $-41,355 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $23,319,549 | $77,927,798 | $20,495,138 | $285,012 |
| Common Stock Issuance | $23,319,549 | $77,927,798 | $20,495,138 | $285,012 |
| Other | ||||
| Repayment Of Debt | $-1,466,413 | $-1,704,482 | $-1,381,469 | $-1,197,049 |
| Issuance Of Debt | $25,148,095 | $11,176,931 | $0 | $0 |
| End Cash Position | $33,531,911 | $38,209,456 | $24,153,348 | $19,993,294 |
| Beginning Cash Position | $38,209,456 | $24,153,348 | $19,993,294 | $151,457,474 |
| Effect Of Exchange Rate Changes | $-1,838,605 | $768,973 | $-412,429 | $2,306,919 |
| Changes In Cash | $-2,838,940 | $13,287,136 | $4,572,482 | $-133,771,099 |
| Interest Paid Cff | $-775,679 | $-554,376 | $-214,597 | $-145,300 |
| Net Issuance Payments Of Debt | $23,681,681 | $9,472,449 | $-1,381,469 | $-1,197,049 |
| Net Long Term Debt Issuance | $23,681,681 | $9,472,449 | $-1,381,469 | $-1,197,049 |
| Long Term Debt Payments | $-1,466,413 | $-1,704,482 | $-1,381,469 | $-1,197,049 |
| Long Term Debt Issuance | $25,148,095 | $11,176,931 | $0 | $0 |
| Interest Received Cfi | $2,405,276 | $2,524,869 | $2,581,871 | $122,946 |
| Net Investment Purchase And Sale | $33,470,438 | $-13,992,400 | $45,448,755 | $-82,381,805 |
| Sale Of Investment | $80,469,432 | $95,352,634 | $134,884,321 | $32,315,861 |
| Purchase Of Investment | $-46,998,995 | $-109,345,034 | $-89,435,566 | $-114,697,666 |
| Net PPE Purchase And Sale | $-896,390 | $-1,294,289 | $-2,794,233 | $-990,276 |
| Sale Of PPE | $3,353 | $7,824 | $0 | $0 |
| Purchase Of PPE | $-899,743 | $-1,302,112 | $-2,794,233 | $-990,276 |
| Taxes Refund Paid | $-1,165,754 | $-597,966 | $-881,860 | $-458,254 |
| Change In Working Capital | $6,003,130 | $3,310,607 | $-3,905,220 | $96,122 |
| Change In Payables And Accrued Expense | $8,332,402 | $5,715,883 | $535,375 | $687,381 |
| Change In Payable | $8,332,402 | $5,715,883 | $535,375 | $687,381 |
| Change In Inventory | $62,591 | $-1,565,888 | $-2,719,347 | $-599,084 |
| Change In Receivables | $-2,391,863 | $-839,388 | $-1,721,247 | $7,824 |
| Other Non Cash Items | $3,080,362 | $-1,057,338 | $-2,179,502 | $-181,066 |
| Stock Based Compensation | $5,461,048 | $4,435,006 | $2,918,297 | $3,015,536 |
| Unrealized Gain Loss On Investment Securities | $57,002 | $0 | $0 | - |
| Provisionand Write Offof Assets | $421,370 | $913,155 | $241,422 | $41,355 |
| Asset Impairment Charge | $1,877,724 | $0 | $0 | - |
| Depreciation Amortization Depletion | $5,011,736 | $3,037,890 | $2,637,756 | $2,159,383 |
| Depreciation And Amortization | $5,011,736 | $3,037,890 | $2,637,756 | $2,159,383 |
| Amortization Cash Flow | $2,492,456 | $1,079,692 | $1,075,221 | $908,684 |
| Amortization Of Intangibles | $2,492,456 | $1,079,692 | $1,075,221 | $908,684 |
| Depreciation | $2,519,280 | $1,958,198 | $1,562,535 | $1,250,699 |
| Gain Loss On Investment Securities | $-1,772,661 | $450,430 | $-282,776 | $3,040,125 |
| Net Foreign Currency Exchange Gain Loss | $3,307,254 | $-2,437,689 | $1,316,642 | $-6,263,552 |
| Gain Loss On Sale Of PPE | $181,066 | $0 | $0 | - |
| Net Income From Continuing Operations | $-99,559,631 | $-63,073,657 | $-49,912,821 | $-33,593,384 |
| Interest Received Cfo | - | $0 | $0 | $3,353 |
Fetched: 2026-10-26